Thus, it appears that SK reduces tamoxifen resistance in MCF-7R BC cells via activating uc.57, which suppressedPI3K/AKT/MAPK signaling pathways via BCL11A downregulation (Zhang et al., 2017). The gene discussed is BCL11A; the disease is breast cancer.